Literature DB >> 7736454

Immunohistochemical characterization of 'small, lymphoid-like cell populations' within germinomas: immunologic and molecular approaches to diagnosis.

T Nitta1, M Hishii, K Sato, K Okumura.   

Abstract

Little is known to date about the biological and molecular characteristics of 'small lymphoid cells' within intracranial germinomas. Frozen sections from three germinoma specimens were evaluated immunohistochemically in order to identify phenotypic markers expressed on human lymphoid cells as well as intercellular adhesion molecules. In addition, T-cell receptor (TCR) variable alpha- and beta-chain mRNA expression was analyzed by polymerase chain reaction (PCR). The small cells stained faintly with anti-CD5 in two specimens, but were negative for the T cell specific markers, CD2, CD3, CD7, and CD8. In addition, these cells were weakly positive for CD11b (Mac-1) and CD54 (ICAM-1), but were negative for lymphocyte-specific CD11a (LFA-1) and CD11c (p150,95). No TCR V alpha or V beta gene expression was detected by PCR within these germinoma specimens. The small cells of germinomas with the cytologic appearance of lymphocytes are not derived from T-cells or other lymphocytic lineages.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7736454     DOI: 10.1016/0304-3835(95)99394-9

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  2 in total

1.  Low tumor cell content predicts favorable prognosis in germinoma patients.

Authors:  Hirokazu Takami; Kaishi Satomi; Kohei Fukuoka; Shintaro Fukushima; Yuko Matsushita; Kai Yamasaki; Taishi Nakamura; Shota Tanaka; Akitake Mukasa; Nobuhito Saito; Tomonari Suzuki; Takaaki Yanagisawa; Hideo Nakamura; Kazuhiko Sugiyama; Kaoru Tamura; Taketoshi Maehara; Mitsutoshi Nakada; Masahiro Nonaka; Akio Asai; Kiyotaka Yokogami; Hideo Takeshima; Toshihiko Iuchi; Yonehiro Kanemura; Keiichi Kobayashi; Motoo Nagane; Kazuhiko Kurozumi; Koji Yoshimoto; Masahide Matsuda; Akira Matsumura; Yuichi Hirose; Tsutomu Tokuyama; Toshihiro Kumabe; Yoshitaka Narita; Soichiro Shibui; Yoichi Nakazato; Ryo Nishikawa; Masao Matsutani; Koichi Ichimura
Journal:  Neurooncol Adv       Date:  2021-08-10

Review 2.  Biomarkers for risk-based treatment modifications for CNS germ cell tumors: Updates on biological underpinnings, clinical trials, and future directions.

Authors:  Hirokazu Takami; Koichi Ichimura
Journal:  Front Oncol       Date:  2022-09-05       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.